Delays to Australia’s vaccine rollout could cost the economy billions

A report has found the delays in Australia’s vaccine rollout could mean 15 more days of lockdown – each costing more than $123 million.

Hand with blue medical gloves holds vials of coronavirus vaccines

Image source: Getty Images

Australia is continuing to face delays of its COVID-19 vaccine rollout and it’s likely to cost the country billions.

Australia’s vaccine rollout was already delayed before the AstraZeneca vaccine was found to put those under 50 at risk of deadly blood clots.

A report by the McKell Institute has found the original delays in our vaccine rollout could result in 15 days of lockdown – each costing the economy more than $123 million.

Now, the golden egg in our basket has broken, what could the economic impact be?

How delayed is Australia’s vaccine rollout so far?

Originally, 4 million Australians were to be vaccinated by the end of March.  Instead, just 1.65 million Australians have been vaccinated. 

The McKell Institute’s report, Counting the Cost of Australia’s Delayed Vaccine Rollout, found to avoid more lockdowns at least 65% of Australians must be vaccinated.

If the rollout continues at its current speed that could take approximately 518 days, or just under 1.5 years.

For Australia to be fully vaccinated by October, the vaccination rollout would have to be up to 15 times faster.

What could delays cost Australia’s economy?

The report found, so far, 13.7% of days have seen an Australian capital city in a COVID-19-induced lockdown.

When most front-line healthcare and quarantine workers receive vaccines, the percentage of likely days in lockdown decreases to approximately 9.5%. 

The report also tallied the costs of various lockdowns around Australia. It found a conservative figure would be roughly $123 million per day.

If Australia’s vaccine rollout continues at its current speed, Australian capitals could see another 49 days of lockdown. This could potentially cost the economy more than $6 billion.

Even if Australia increased its vaccination rollout to 15 times its current speed tomorrow, we would likely see an extra 11.1 days of lockdowns – costing upwards of $1.36 billion.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here’s how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here’s what Rio Tinto (ASX:RIO) boss says is ‘causing some challenges’ right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.

CBA reveals the Australian economy’s leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »